Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2022

Open Access 01-12-2022 | Biomarkers | Review

Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders

Authors: Majid Ghasemian, Masoumeh Rajabibazl, Unes Sahebi, Samira Sadeghi, Reza Maleki, Veys Hashemnia, Reza Mirfakhraie

Published in: Cancer Cell International | Issue 1/2022

Login to get access

Abstract

MIR4435-2HG (LINC00978) is a long non-coding RNA (lncRNA) that acts as an oncogene in almost all cancers. This lncRNA participates in the molecular cascades involved in other disorders such as coronary artery diseases, osteonecrosis, osteoarthritis, osteoporosis, and periodontitis. MIR4435-2HG exerts its functions via the spectrum of different mechanisms, including inhibition of apoptosis, sponging microRNAs (miRNAs), promoting cell proliferation, increasing cell invasion and migration, and enhancing epithelial to mesenchymal transition (EMT). MIR4435-2HG can regulate several signaling pathways, including Wnt, TGF-β/SMAD, Nrf2/HO-1, PI3K/AKT, MAPK/ERK, and FAK/AKT/β‑catenin signaling pathways; therefore, it can lead to tumor progression. In the present review, we aimed to discuss the potential roles of lncRNA MIR4435-2HG in developing cancerous and non-cancerous conditions. Due to its pivotal role in different disorders, this lncRNA can serve as a potential biomarker in future investigations. Moreover, it may serve as a potential therapeutic target for the treatment of various diseases.
Literature
1.
2.
3.
Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res: GCR. 2012;5:19.PubMedPubMedCentral
4.
Xu S-p, Zhang J-f, Sui S-y, Bai N-x, Gao S, Zhang G-w, et al. Downregulation of the long noncoding rna egot correlates with malignant status and poor prognosis in breast cancer. Tumor Biol. 2015;36:9807–12.CrossRef
5.
Kangarlouei R, Irani S, Noormohammadi Z, Memari F, Mirfakhraie R. Anril and anrassf1 long noncoding rnas are upregulated in gastric cancer. J Cell Biochem. 2019;120:12544–8.PubMedCrossRef
6.
Sadeghi H, Nazemalhosseini-Mojarad E, Sahebi U, Fazeli E, Azizi-Tabesh G, Yassaee VR, et al. Novel long noncoding rnas upregulation may have synergistic effects on the cyp24a1 and pfdn4 biomarker role in human colorectal cancer. J Cell Physiol. 2021;236:2051–7.PubMedCrossRef
7.
Esmkhani S, Sadeghi H, Ghasemian M, Pirjani R, Amin-Beidokhti M, Gholami M, et al. Contribution of long noncoding rna hotair variants to preeclampsia susceptibility in iranian women. Hypertens Pregnancy. 2021;40:29–35.PubMedCrossRef
8.
9.
Xiong J, Liu Y, Luo S, Jiang L, Zeng Y, Chen Z, et al. High expression of the long non-coding rna heircc promotes renal cell carcinoma metastasis by inducing epithelial-mesenchymal transition. Oncotarget. 2017;8:6555.PubMedCrossRef
10.
11.
Carlevaro-Fita J, Lanzós A, Feuerbach L, Hong C, Mas-Ponte D, Pedersen JS, et al. Cancer lncrna census reveals evidence for deep functional conservation of long noncoding rnas in tumorigenesis. Commun Biol. 2020;3:1–16.CrossRef
12.
Tang T, Wang B. Clinical significance of lncrna-awpph in coronary artery diseases. Eur Rev Med Pharmacol Sci. 2020;24:11747–51.PubMed
13.
Chen X, Li J, Liang D, Zhang L, Wang Q. Lncrna awpph participates in the development of non-traumatic osteonecrosis of femoral head by upregulating runx2. Exp Ther Med. 2020;19:153–9.PubMed
14.
Xiao Y, Bao Y, Tang L, Wang L. Lncrna mir4435-2hg is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis. J Orthop Surg Res. 2019;14:1–5.CrossRef
15.
16.
17.
18.
Dong X, Yang Z, Yang H, Li D, Qiu X. Long non-coding rna mir4435-2hg promotes colorectal cancer proliferation and metastasis through mir-206/yap1 axis. Front Oncol. 2020;10:160.PubMedPubMedCentralCrossRef
19.
Luo P, Wu S, Ji K, Yuan X, Li H, Chen J, et al. Lncrna mir4435-2hg mediates cisplatin resistance in hct116 cells by regulating nrf2 and ho-1. PLoS ONE. 2020;15: e0223035.PubMedPubMedCentralCrossRef
20.
Bai J, Xu J, Zhao J, Zhang R. Downregulation of lncrna awpph inhibits colon cancer cell proliferation by downregulating glut-1. Oncol Lett. 2019;18:2007–12.PubMedPubMedCentral
21.
Ghasemian M, Rajabibazl M, Mirfakhraie R, Razavi AE, Sadeghi H. Long noncoding rna linc00978 acts as a potential diagnostic biomarker in patients with colorectal cancer. Exp Mol Pathol. 2021;122: 104666.PubMedCrossRef
22.
Shen M, Zhou G, Zhang Z. Lncrna mir4435-2hg contributes into colorectal cancer development and predicts poor prognosis. Eur Rev Med Pharmacol Sci. 2020;24:1771–7.PubMed
23.
24.
Barrera G, Cucci MA, Grattarola M, Dianzani C, Muzio G, Pizzimenti S. Control of oxidative stress in cancer chemoresistance: spotlight on nrf2 role. Antioxidants. 2021;10:510.PubMedPubMedCentralCrossRef
25.
Wang X-J, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of nrf2. Carcinogenesis. 2008;29:1235–43.PubMedPubMedCentralCrossRef
26.
Ke D, Li H, Zhang Y, An Y, Fu H, Fang X, et al. The combination of circulating long noncoding rnas ak001058, inhba-as1, mir4435-2hg, and cebpa-as1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget. 2017;8:21516.PubMedPubMedCentralCrossRef
27.
Fu M, Huang Z, Zang X, Pan L, Liang W, Chen J, et al. Long noncoding rna linc 00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer. Cell Prolif. 2018;51: e12425.CrossRef
28.
Bu J-Y, Lv W-Z, Liao Y-F, Xiao X-Y, Lv B-J. Long non-coding rna linc00978 promotes cell proliferation and tumorigenesis via regulating microrna-497/ntrk3 axis in gastric cancer. Int J Biol Macromol. 2019;123:1106–14.PubMedCrossRef
29.
Gao L-F, Li W, Liu Y-G, Zhang C, Gao W-N, Wang L. Inhibition of mir4435–2hg on invasion, migration, and emt of gastric carcinoma cells by mediating mir-138–5p/sox4 axis. Front Oncol. 2021;11:3057.
30.
31.
Sabbadini F, Bertolini M, De Matteis S, Mangiameli D, Contarelli S, Pietrobono S, et al. The multifaceted role of tgf-β in gastrointestinal tumors. Cancers. 2021;13:3960.PubMedPubMedCentralCrossRef
32.
Liu S, Ren J, Ten Dijke P. Targeting tgfβ signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:1–20.CrossRef
33.
Han Q, Chen B, Zhang K, Xia S, Zhong W, Zhao Z. The long non-coding rna ak001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2019;23:2013–9.PubMed
34.
Zhao X, Liu Y, Yu S. Long noncoding rna awpph promotes hepatocellular carcinoma progression through ybx1 and serves as a prognostic biomarker. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2017;1863:1805–16.CrossRef
35.
Kong Q, Liang C, Jin Y, Pan Y, Tong D, Kong Q, et al. The lncrna mir4435-2hg is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating mirna-487a. Cell Mol Biol Lett. 2019;24:1–7.CrossRef
36.
Xu X, Gu J, Ding X, Ge G, Zang X, Ji R, et al. Linc00978 promotes the progression of hepatocellular carcinoma by regulating ezh2-mediated silencing of p21 and e-cadherin expression. Cell Death Dis. 2019;10:1–15.CrossRef
37.
Zhang Q, Cheng S, Cao L, Yang J, Wang Y, Chen Y. Linc00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the mapk/erk pathway. Biosci Rep. 2020;40:BSR20192790.PubMedPubMedCentralCrossRef
38.
Zhu Y, Li B, Xu G, Han C, Xing G. Lncrna mir4435-2hg promotes the progression of liver cancer by upregulating b3gnt5 expression. Mol Med Rep. 2022;25:1–11.
39.
Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, et al. Translational activation of snail1 and other developmentally regulated transcription factors by yb-1 promotes an epithelial-mesenchymal transition. Cancer Cell. 2009;15:402–15.PubMedCrossRef
40.
Astanehe A, Finkbeiner M, Hojabrpour P, To K, Fotovati A, Shadeo A, et al. The transcriptional induction of pik3ca in tumor cells is dependent on the oncoprotein y-box binding protein-1. Oncogene. 2009;28:2406–18.PubMedCrossRef
41.
Moritz LE, Trievel RC. Structure, mechanism, and regulation of polycomb-repressive complex 2. J Biol Chem. 2018;293:13805–14.PubMedCrossRef
42.
43.
Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J, et al. A novel long noncoding rna ak001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol. 2015;285:79–88.PubMedCrossRef
44.
Qian H, Chen L, Huang J, Wang X, Ma S, Cui F, et al. The lncrna mir4435-2hg promotes lung cancer progression by activating β-catenin signalling. J Mol Med. 2018;96:753–64.PubMedCrossRef
45.
Li X, Ren Y, Zuo T. Long noncoding rna linc00978 promotes cell proliferation and invasion in non-small cell lung cancer by inhibiting mir-6754-5p. Mol Med Rep. 2018;18:4725–32.PubMed
46.
Wu D, Qin B, Qi X, Hong L, Zhong H, Huang J. Lncrna awpph accelerates the progression of non-small cell lung cancer by sponging mirna-204 to upregulate cdk6. Eur Rev Med Pharmacol Sci. 2020;24:4281–7.PubMed
47.
Deng L-l, Chi Y-y, Liu L, Huang N-s, Wang L, Wu J. Linc00978 predicts poor prognosis in breast cancer patients. Sci Rep. 2016;6:1–7.CrossRef
48.
49.
Liu AN, Qu HJ, Gong WJ, Xiang JY, Yang MM, Zhang W. Lncrna awpph and mirna-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other. J Cell Biochem. 2019;120:14860–6.PubMedCrossRef
50.
Gong J, Xu X, Zhang X, Zhou Y. Lncrna mir4435-2hg is a potential early diagnostic marker for ovarian carcinoma. Acta Biochim Biophys Sin. 2019;51:953–9.PubMedCrossRef
51.
Zhu L, Wang A, Gao M, Duan X, Li Z. Lncrna mir4435-2hg triggers ovarian cancer progression by regulating mir-128-3p/ckd14 axis. Cancer Cell Int. 2020;20:1–16.CrossRef
52.
Xing P, Wang Y, Zhang L, Ma C, Lu J. Knockdown of lncrna mir4435-2hg and st8sia1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the fak/akt/β-catenin signaling pathway. Int J Mol Med. 2021;47:1–13.CrossRef
53.
Zhang H, Meng H, Huang X, Tong W, Liang X, Li J, et al. Lncrna mir4435-2hg promotes cancer cell migration and invasion in prostate carcinoma by upregulating tgf-β1. Oncol Lett. 2019;18:4016–21.PubMedPubMedCentral
54.
Nguyen K, Yan Y, Yuan B, Dasgupta A, Sun J, Mu H, et al. St8sia1 regulates tumor growth and metastasis in tnbc by activating the fak–akt–mtor signaling pathway. Mol Cancer Ther. 2018;17:2689–701.PubMedPubMedCentralCrossRef
55.
Shan Y, Liu Y, Zhao L, Liu B, Li Y, Jia L. Microrna-33a and let-7e inhibit human colorectal cancer progression by targeting st8sia1. Int J Biochem Cell Biol. 2017;90:48–58.PubMedCrossRef
56.
Yu S, Wang S, Sun X, Wu Y, Zhao J, Liu J, et al. St8sia1 inhibits the proliferation, migration and invasion of bladder cancer cells by blocking the jak/stat signaling pathway. Oncol Lett. 2021;22:1–11.CrossRef
57.
Drabsch Y, Ten Dijke P. Tgf-β signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev. 2012;31:553–68.PubMedCrossRef
58.
Xu H, Zhang B, Yang Y, Li Z, Zhao P, Wu W, et al. Lncrna mir4435-2hg potentiates the proliferation and invasion of glioblastoma cells via modulating mir-1224-5p/tgfbr2 axis. J Cell Mol Med. 2020;24:6362–72.PubMedPubMedCentralCrossRef
59.
Dai B, Xiao Z, Mao B, Zhu G, Huang H, Guan F, et al. Lncrna awpph promotes the migration and invasion of glioma cells by activating the tgf-β pathway. Oncol Lett. 2019;18:5923–9.PubMedPubMedCentral
60.
Elbediwy A, Thompson BJ. Evolution of mechanotransduction via yap/taz in animal epithelia. Curr Opin Cell Biol. 2018;51:117–23.PubMedCrossRef
61.
Shen W, Zhang J, Pan Y, Jin Y. Lncrna mir4435-2hg functions as a cerna against mir-125a-5p and promotes neuroglioma development by upregulating taz. J Clin Lab Anal. 2021;35: e24066.PubMedPubMedCentralCrossRef
62.
Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J. Novel insights into the roles of rho kinase in cancer. Arch Immunol Ther Exp. 2016;64:259–78.CrossRef
63.
64.
Li X, Song F, Sun H. Long non-coding rna awpph interacts with rock2 and regulates the proliferation and apoptosis of cancer cells in pediatric t-cell acute lymphoblastic leukemia. Oncol Lett. 2020;20:1.
65.
Cai Z, Aguilera F, Ramdas B, Daulatabad SV, Srivastava R, Kotzin JJ, et al. Targeting bim via a lncrna morrbid regulates the survival of preleukemic and leukemic cells. Cell Rep. 2020;31: 107816.PubMedPubMedCentralCrossRef
66.
Wang R, Liu L, Jiao J, Gao D. Knockdown of mir4435-2hg suppresses the proliferation, migration and invasion of cervical cancer cells via regulating the mir-128-3p/msi2 axis in vitro. Cancer Manage Res. 2020;12:8745.CrossRef
67.
Wu K, Hu L, Lv X, Chen J, Yan Z, Jiang J, et al. Long non-coding rna mir4435-1hg promotes cancer growth in clear cell renal cell carcinoma. Cancer Biomark. 2020;29:39–50.PubMedCrossRef
68.
Zhu K, Miao C, Tian Y, Qin Z, Xue J, Xia J, et al. Lncrna mir4435-2hg promoted clear cell renal cell carcinoma malignant progression via mir-513a-5p/klf6 axis. J Cell Mol Med. 2020;24:10013–26.PubMedPubMedCentralCrossRef
69.
Liu B, Pan C-F, Yao G-L, Wei K, Xia Y, Chen Y-J. The long non-coding rna ak001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma. Cancer Cell Int. 2018;18:1–8.CrossRef
70.
Wang S, Chen X, Qiao T. Long non-coding rna mir4435-2hg promotes the progression of head and neck squamous cell carcinoma by regulating the mir-383-5p/rbm3 axis. Oncol Rep. 2021;45:1–10.CrossRef
71.
Wang W, Xu Z, Wang J, Chen R. Linc00978 promotes bladder cancer cell proliferation, migration and invasion by sponging mir-4288. Mol Med Rep. 2019;20:1866–72.PubMed
72.
Ma D, Sun D, Wang J, Jin D, Li Y, Han Y. Long non-coding rna mir4435-2hg recruits mir-802 from flot2 to promote melanoma progression. Eur Rev Med Pharmacol Sci. 2020;24:2616–24.PubMed
73.
Guo D, Liu F, Zhang L, Bian N, Liu L, Kong L, et al. Long non-coding rna awpph enhances malignant phenotypes in nasopharyngeal carcinoma via silencing pten through interacting with lsd1 and ezh2. Biochem Cell Biol. 2021;99:195–202.PubMedCrossRef
74.
Zhao L, Lin L, Pan C, Shi M, Liao Y, Bin J, et al. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β. Oncotarget. 2015;6:9781.PubMedPubMedCentralCrossRef
75.
Huang S, Zheng S, Huang S, Cheng H, Lin Y, Wen Y, et al. Flot2 targeted by mir-449 acts as a prognostic biomarker in glioma. Artif Cells Nanomed Biotechnol. 2019;47:250–5.PubMedCrossRef
76.
Zhang X, Yang M, Lin L, Chen P, Ma K, Zhou C, et al. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif Tissue Int. 2006;79:169–78.PubMedCrossRef
77.
Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, et al. Bmp2 regulates osterix through msx2 and runx2 during osteoblast differentiation∗. J Biol Chem. 2008;283:29119–25.PubMedPubMedCentralCrossRef
78.
Pengde K, Fuxing P, Bin S, Jing Y, Jingqiu C. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine. 2008;75:696–701.PubMedCrossRef
79.
Hartana CA, Rassadkina Y, Gao C, Martin-Gayo E, Walker BD, Lichterfeld M, et al. Long noncoding rna mir4435-2hg enhances metabolic function of myeloid dendritic cells from hiv-1 elite controllers. J Clin Investig. 2021;131: e146136.PubMedCentralCrossRef
80.
Zheng Y, Song D, Xiao K, Yang C, Ding Y, Deng W, et al. Lncrna gas5 contributes to lymphatic metastasis in colorectal cancer. Oncotarget. 2016;7:83727.PubMedPubMedCentralCrossRef
81.
Xie X, Tang B, Xiao Y-F, Xie R, Li B-S, Dong H, et al. Long non-coding rnas in colorectal cancer. Oncotarget. 2016;7:5226.PubMedCrossRef
Metadata
Title
Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
Authors
Majid Ghasemian
Masoumeh Rajabibazl
Unes Sahebi
Samira Sadeghi
Reza Maleki
Veys Hashemnia
Reza Mirfakhraie
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Biomarkers
Published in
Cancer Cell International / Issue 1/2022
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-022-02633-8

Other articles of this Issue 1/2022

Cancer Cell International 1/2022 Go to the issue

Primary research

LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes

Research

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53

Hypothesis

New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells

Research

Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient

Primary research

Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell–mediated cytotoxicity and PD-1 checkpoint

Review

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits